Ten new hires get Vera stock awards tied to 60,375 shares
Vera Therapeutics (Nasdaq: VERA) announced inducement awards on May 4, 2026, granting non-qualified stock options for 40,250 shares and Restricted Stock Units (RSUs) for 20,125 shares to ten new employees under its 2024 Inducement Plan. The stock options have an exercise price of $35.51, matching the closing price on the grant date, and both options and RSUs will vest over four years, subject to continued employment. This move follows similar grants and aims to attract and retain talent in line with Nasdaq Listing Rule 5635(c)(4).
MAY 8·GlobeNewswire→
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Vera Therapeutics has announced inducement awards for ten new employees, consisting of non-qualified stock options to purchase 40,250 shares and restricted stock units (RSUs) underlying 20,125 shares of Class A common stock. These grants were made on May 4, 2026, under the company's 2024 Inducement Plan, with an exercise price of $35.51 per stock option. The awards are structured with vesting schedules over four years, contingent on continued employment.
APR 10·GlobeNewswire▲
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Vera Therapeutics, Inc. announced inducement awards to 89 new employees, consisting of non-qualified stock options to purchase 258,200 shares and restricted stock units (RSUs) for 131,925 shares of Class A common stock. These grants were made under the company's 2024 Inducement Plan and approved by the Compensation Committee in accordance with Nasdaq Listing Rule 5635(c)(4). The stock options and RSU awards will vest over four years, subject to continued employment.
